First Tracks Biotherapeutics stock surges 20% on celiac trial data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| (NASDAQ: TRAX) | Delayed: 35.06 +3.21 (10.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.85 | 52 Week High | $ | |||
| Open | $39.45 | 52 Week Low | $ | |||
| Day High | $40.50 | P/E | N/A | |||
| Day Low | $33.56 | EPS | $ | |||
| Volume | 4,601,294 | |||||
